Shockwave Appoints Keith D. Dawkins M.D. as Chief Medical Officer

SANTA CLARA, Calif., May 15, 2019 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the Company has appointed Keith D. Dawkins, M.D. as Chief Medical Officer. “Given the challenges associated […]

Neovasc Announces Private Placement of Convertible Debt and Equity for Gross Proceeds of US$11.5 Million

VANCOUVER, May 14, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that it has entered into an agreement to sell to […]

John Fletcher Named Strategic Advisor to Micro Medical Solutions

WILMINGTON, Mass., May 14, 2019 /PRNewswire/ — Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced today that John Fletcher has signed on as a strategic advisor to the company’s senior management. Mr. Fletcher is the founder and leader of healthcare consulting and […]

Ra Medical Systems Reports First Quarter 2019 Financial Results

CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports financial results for the three months ended March 31, 2019 and provides a business update. Recent Operational Highlights Submitted an Investigational Device Exemption (IDE) to the […]

Exelixis’ Collaborator Daiichi Sankyo Launches MINNEBRO® (Esaxerenone) Tablets in Japan

ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced its partner Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) has launched MINNEBRO® (esaxerenone) tablets as a treatment for patients with hypertension in Japan. With Daiichi Sankyo’s first commercial sale of MINNEBRO, Exelixis will receive an associated $20 million milestone payment from Daiichi Sankyo under […]

BD Announces Results for 2019 Second Fiscal Quarter; Updates Fiscal 2019 Guidance

– As reported, revenues of $4.195 billion decreased 0.6 percent. – On a comparable, currency-neutral basis, revenues increased 3.4 percent. – As reported, diluted earnings per share of $(0.07) increased 63.2 percent. – As adjusted, diluted earnings per share of $2.59 decreased 2.3 percent, and increased 7.2 percent on a […]

Neovasc Announces First Quarter 2019 Financial Results

NASDAQ, TSX: NVCN Recent Highlights Announced the 1,000th recipient of a Neovasc ReducerTM (“Reducer”) implant Company sponsored Reducer Symposium attended by over 100 attendees at the 85th Annual Conference of the German Society of Cardiology (“DGK”) Completed the conceptual work for the TF/TS TiaraTM (“Tiara”) system; planning to initiate a small clinical feasibility […]